Saving changes...

Done

Error

Virtual Patient: Young Girl with Peanut Allergy

Virtual Patient: Young Girl with Peanut Allergy

Virtual Patient: Young Girl with Peanut Allergy

Anna H. Wegrzyn (MD FAAAAI) and Mike Tankersley (MD FAAAAI)
Anna H. Wegrzyn (MD FAAAAI) and Mike Tankersley (MD FAAAAI)
on behalf of American Academy of Allergy Asthma & Immunology

$10.00 $ 10.00 $ 10.00

$10.00 $ 10.00 $ 10.00

$ 10.00 $ 10.00 $ 10.00
$ 10.00 $ 10.00 $ 10.00
Normal Price: $10.00 $10.00

Review:

Launch date: 29 Jun 2018
Expiry Date:

Last updated: 22 Aug 2018

Reference: 190495

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This patient simulation involves a young girl with severe peanut allergy whose parents are interested in a desensitization treatment, like oral immunotherapy (OIT). During the consultation, her parents ask several questions about the administration, safety, efficacy, and effects of peanut/food oral immunotherapy. The findings from food OIT clinical trials will be referenced to answer these questions.

Objectives

Discuss the current FDA approval status of food OIT treatments
Upon completion of this activity, participants should be able to discuss the current FDA approval status of food OIT treatments.
Summarize findings from studies regarding administration, duration, safety, efficacy, and cross-reactivity of food OIT
Upon completion of this activity, participants should be able to summarize findings from studies regarding administration, duration, safety, efficacy, and cross-reactivity of food OIT.
Explain how desensitization is measured and how to minimize the risk of a reaction during OIT by avoiding so-called augmentation factors
Upon completion of this activity, participants should be able to explain how desensitization is measured and how to minimize the risk of a reaction during OIT by avoiding so-called augmentation factors.
Anna H. Wegrzyn (MD FAAAAI) and Mike Tankersley (MD FAAAAI)

Author Information Play Video Bio

Anna H. Wegrzyn (MD FAAAAI) and Mike Tankersley (MD FAAAAI)
on behalf of American Academy of Allergy Asthma & Immunology

Anna H. Nowak-Wegrzyn, MD FAAAAI
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant Financial Disclosures: DBV, Nutricia: research funding

Mike Tankersley, MD FAAAAI
University of Tennessee Health Science Center, Memphis, TN
Relevant Financial Disclosures: None

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Continuing Medical Education (ACCME)
  • 0.25 Credits
  • California Board of Registered Nursing (CBRN)
  • 0.25 Hours

Faculty and Disclosures

Anna H. Nowak-Wegrzyn, MD FAAAAI

Anna H. Nowak-Wegrzyn, MD FAAAAI

Relevant Financial Disclosures: DBV, Nutricia: research funding
Mike Tankersley, MD FAAAAI

Mike Tankersley, MD FAAAAI

Relevant Financial Disclosures: None

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error